期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

通用转录因子GTFⅡF2对食管癌细胞增殖、迁移的影响

The effect of general transcription factor GTFⅡF2 expression on the proliferation and migration of esophageal cancer cells
下载PDF
导出
摘要 目的研究通用转录因子ⅡF多肽2(GTFⅡF2)的表达对食管癌细胞增殖及迁移的影响。方法人工合成靶向GTFⅡF2基因的siRNA序列和阴性对照siRNA序列及质粒pc DNA3.1-GTFⅡF2-FLAG,分别转染至食管癌细胞中,采用克隆形成实验和细胞划痕实验观察其对食管癌细胞增殖和迁移的影响。结果 RNA干扰技术靶向沉默GTFⅡF2基因表达后,食管癌细胞增殖和迁移均明显受到了抑制,而过表达GTFⅡF2对食管癌细胞的增殖和迁移无明显影响。结论GTFⅡF2基因在食管癌细胞TE-1、ECA-109的增殖和迁移过程中发挥重要作用,为进一步了解GTFⅡF2基因抑制TE-1、ECA-109细胞增殖和迁移的机制提供了基础。 Objective To investigate the effect of general transcription factor GTFⅡF2 expression on the proliferation and migration of esophageal cancer cells. Methods Synthesized siRNA targeted to GTFⅡF2 gene or negative control siRNA and plasmid pc DNA3. 1-GTFⅡF2-FLAG were transfected to esophageal cancer cells respectively by using LipofectamineTM2000. Colony formation assay and wound-healing assay were performed to study the effect of knockdown and overexpression of GTFⅡF2 expression on the proliferation and migration of esophageal cancer cells respectively. Results Knockdown of GTFⅡF2 inhibited the proliferation and migration in TE-1,ECA-109 cells,but overexpression of GTFⅡF2 had no significant effect on cell proliferation and migration. Conclusion GTFⅡF2gene plays an important role in the proliferation and migration of TE-1,ECA-109 cells. It is useful for further understanding of the mechanism that GTFⅡF2 inhibits the proliferation and migration of TE-1,ECA-109 cells.
作者 陈丹丹 耿慧武 潘林鑫 刘晓颖 范礼斌
机构地区 安徽医科大学生命科学学院生物教研室
出处 《安徽医科大学学报》 CAS 北大核心 2016年第7期984-989,共6页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金青年基金(编号:81201368)
关键词 GTFⅡF2 基因表达 RNA干扰 细胞增殖 细胞迁移 GTFⅡF2 gene expression RNA interference cell proliferation cell migration
分类号 R735.1 [医药卫生—肿瘤]
  • 相关文献

参考文献11

  • 1Sopta M, Burton Z F, Greenblatt J. Structure and associated DNA-helicase activity of a general transcription initiation factor that binds to RNA polymerase Ⅱ [ J ]. Nature, 1989,341 ( 6241 ) :410 - 4.
  • 2Bansard C, Lequerr6 T, Derambure C, et al. Gene profiling pre- dicts rheumatoid arthritis responsiveness to IL-1Ra (anakinra) [J]. Rheumatology,2011,50(2) :283 -92.
  • 3Kaplan A, Stockwell B R. Therapeutic approaches to preventing cell death in Huntington disease [ J 1. Prog Neurobiol, 2012,99 (3) :262 -80.
  • 4Kitajima S, Chibazakura T, Yonaha M, et al. Regulation of the human general transcription initiation factor TF lI F by phosphoryl- ation [ J ]. J Biol Chem, 1994, 269 (47) :29970 - 7.
  • 5钱成,王蓓华,徐雪琴,潘林鑫,李新颖,刘晓颖,范礼斌.肌营养不良蛋白及其衍生物的表达与定位的研究[J].安徽医科大学学报,2015,50(9):1207-1210. 被引量：3
  • 6Zhai W, Jeong H, Cui L, et al. In Vitro analysis of huntingtin- mediated transcriptional repression reveals multiple transcription factor targets [ J ]. Cell,2005,123 (7) : 1241 - 53.
  • 7Thomas M C, Chiang C M. The general transcription machinery and general cofactors [ J]. Crit Rev Biochem Mol Biol,2006, 41 (3) :105 -78.
  • 8Flores O, Ha I, Reinberg D. Factors involved in specific tran- scription by mammalian RNA polymerase Ⅱ. Purification and sub- unit composition of transcription factor Ⅱ F[ J]. J Biol Chem, 1990, 265 (10) :5629 - 34.
  • 9Tan S, Garrett K P, Conaway R C, et al. Cryptic DNA-binding domain in the C terminus of RNA polymerase Ⅱ general transcrip-tion factor RAP30[ J]. Proc Natl Acad Sci ,1994,91 (21) :9808 - 12.
  • 10Sawadogo M, Sentenac A. RNA polymcrase B (Ⅱ) and general transcription factors[ J]. Annu Rev Biochem, 1990,59:711 - 54.

二级参考文献15

  • 1Gintjee T J, Magh A S, Bertoni C. High throughput screening in duchenne muscular dystrophy: from drug discovery to functional genomics [ J 3. Biology ( Basel), 2014, 3 (4) :752 - 80.
  • 2Bushby K, Finkel R, Birnkrant D J, et al. Diagnosis and manage- ment of Duchenne muscular dystrophy, part 1 : diagnosis, and phar- macological and psychosocial management [J]. Lancet Neurol, 2010, 9(1) :77 -93.
  • 3Winder S J. The complexities of dystroglycan[ J]. Trends Biochem Sci, 2001, 26(2) :118 -24.
  • 4Winder S J. The membrane-cytoskeleton interface : the role of dys- trophin and utrophin [ J ]. J Muscle Res Cell Motil, 1997, 18 (6) : 617 -29.
  • 5Herzog C, Has C, Franzke C W, et al. Dystroglycan in skin and cutaneous cells: beta-subunit is shed from the cell surface[ J]. J Invest Dermatol, 2004, 122(6) : 1372 -80.
  • 6Dekkers L C, van der Plas M C, van Loenen P B, et al. Embry- onic expression patterns of the Drosophila dystrophin-associated glycoprotein complex orthologs [ J ]. Gene Expr Patterns, 2004, 4 (2) :153 -9.
  • 7Sgambato A, Brancaccio A. -Fhe dystroglycan complex: from biology to cancer[J]. J Cell Physiol, 2005, 205(2) :163 -9.
  • 8Spence H J, Chen Y J, Batchelor C L, et al. Ezrin-dependent regulation of the actin cytoskeleton by beta-dystroglycan [ J ]. Hum Mol Genet, 2004, 13 ( 15 ) : 1657 - 68.
  • 9Michele D E, Campbell K P. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function [ J ]. J Biol Chem, 2003, 278 ( 18 ) : 15457 - 60.
  • 10Brennan P A, Jing J, Ethunandan M, et al. Dystroglycan complex in cancer[ J]. Eur J Surg Oncol (EJSO), 2004, 30(6): 589 - 92.

共引文献2

安徽医科大学学报
2016年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部